Two Double Blind Placebo Controlled Multi Center Multi National Studies (Phase III) to Evaluate the Safety and Efficacy of Sarizotan in Patients With Parkinsons Disease Suffering From Treatment Related Dyskinesia

Grants and Contracts Details

StatusFinished
Effective start/end date4/1/045/31/04

Funding

  • Monitoring Force